Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Asset disposition
Appointed CFO
Quarterly results
Appointed director
CC transcript
|
|
CELGENE CORP (CELG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2020 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 2,241 shares
@ $102.28, valued at
$229.2k
Exercised (in-or-at-the-money) 38,979 options to buy
@ $5.88, valued at
$229.2k
|
|
| 07/06/2020 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Bought 108,108 shares
@ $92.5, valued at
$10M
|
|
| 02/10/2020 |
SC 13G
| CELGENE CORP reports a 7.5% stake in Sutro Biopharma, Inc. |
| 02/10/2020 |
SC 13G/A
| CELGENE CORP reports a 4.2% stake in BeiGene, Ltd. |
| 12/13/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/09/2019 |
S-4 POS
| Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments: |
| 12/09/2019 |
S-4 POS
| Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments: |
| 12/09/2019 |
S-4 POS
| Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/09/2019 |
S-4 POS
| Form S-4 POS - Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments: |
| 12/02/2019 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
| 11/22/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Financial Statement... |
| 11/22/2019 |
4
| VESSEY RUPERT (PRES., RESEARCH AND EARLY DEV.) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 8,634 shares
@ $0
Granted 13,906 shares
@ $0
Granted 24,209 shares
@ $0
Disposed/sold 60,927 shares
@ $0
Disposed/sold 613 shares
@ $0
Disposed/sold 19,142 options to buy
@ $118.57, valued at
$2.3M
Disposed/sold 3,125 options to buy
@ $109.9, valued at
$343.4k
Disposed/sold 3,125 options to buy
@ $132.56, valued at
$414.3k
Disposed/sold 3,125 options to buy
@ $114.08, valued at
$356.5k
Disposed/sold 2,344 options to buy
@ $100.8, valued at
$236.3k
Disposed/sold 9,680 options to buy
@ $104.97, valued at
$1M
|
|
| 11/22/2019 |
4
| AHMED NADIM (PRES., GLOBAL HEM. AND ONC.) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Disposed/sold 6,563 options to buy
@ $113.18, valued at
$742.8k
Disposed/sold 3,125 options to buy
@ $124.06, valued at
$387.7k
Disposed/sold 3,125 options to buy
@ $135.41, valued at
$423.2k
Disposed/sold 5,000 options to buy
@ $100.97, valued at
$504.9k
Disposed/sold 5,000 options to buy
@ $103.26, valued at
$516.3k
Disposed/sold 10,548 options to buy
@ $83.13, valued at
$876.9k
Disposed/sold 10,548 options to buy
@ $88.91, valued at
$937.8k
Disposed/sold 10,549 options to buy
@ $71.43, valued at
$753.5k
Disposed/sold 1,563 restricted stock units
@ $0
Disposed/sold 2,500 restricted stock units
@ $0
Disposed/sold 5,357 restricted stock units
@ $0 |
|
| 11/22/2019 |
4
| AHMED NADIM (PRES., GLOBAL HEM. AND ONC.) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 8,035 shares
@ $0
Granted 17,840 shares
@ $0
Disposed/sold 40,694 shares
@ $0
Disposed/sold 1,966 shares
@ $0
Disposed/sold 1,750 options to buy
@ $36.36, valued at
$63.6k
Disposed/sold 5,624 options to buy
@ $36.47, valued at
$205.1k
Disposed/sold 5,626 options to buy
@ $36.68, valued at
$206.4k
Disposed/sold 9,000 options to buy
@ $40.22, valued at
$362k
Disposed/sold 5,626 options to buy
@ $49.48, valued at
$278.4k
Disposed/sold 3,750 options to buy
@ $59.24, valued at
$222.2k
Disposed/sold 3,750 options to buy
@ $71.33, valued at
$267.5k
|
|
| 11/22/2019 |
4
| Alles Mark J (CEO, CHAIRMAN OF BOARD) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 25,696 shares
@ $0
Granted 45,119 shares
@ $0
Granted 74,414 shares
@ $0
Disposed/sold 366,495 shares
@ $0
Disposed/sold 6,252 shares
@ $0
Disposed/sold 10,994 options to buy
@ $36.96, valued at
$406.3k
Disposed/sold 8,326 options to buy
@ $36.47, valued at
$303.6k
Disposed/sold 8,326 options to buy
@ $34.7, valued at
$288.9k
Disposed/sold 8,326 options to buy
@ $36.68, valued at
$305.4k
Disposed/sold 17,500 options to buy
@ $40.22, valued at
$703.9k
Disposed/sold 12,488 options to buy
@ $49.48, valued at
$617.9k
|
|
| 11/22/2019 |
4
| Alles Mark J (CEO, CHAIRMAN OF BOARD) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Disposed/sold 29,669 options to buy
@ $102.18, valued at
$3M
Disposed/sold 29,669 options to buy
@ $113.18, valued at
$3.4M
Disposed/sold 33,880 options to buy
@ $124.06, valued at
$4.2M
Disposed/sold 33,881 options to buy
@ $135.41, valued at
$4.6M
Disposed/sold 33,881 options to buy
@ $100.97, valued at
$3.4M
Disposed/sold 33,881 options to buy
@ $103.26, valued at
$3.5M
Disposed/sold 59,234 options to buy
@ $83.13, valued at
$4.9M
Disposed/sold 59,234 options to buy
@ $88.91, valued at
$5.3M
Disposed/sold 59,234 options to buy
@ $71.43, valued at
$4.2M
Disposed/sold 17,131 restricted stock units
@ $0
Disposed/sold 30,079 options to buy
@ $0 |
|
|
|
|